
Capegard 500mg Tablet
Salt Composition: Capecitabine
Expiry Date: 01/2028
Inclusive of all taxes
10 tablet
About The Product
- Colorectal Cancer
- Breast Cancer
- Stomach (Gastric) Cancer
- Pancreatic Cancer
Capegard 500mg tablet is a chemotherapy-based anticancer medicine. It is prescribed to treat breast cancer, colon cancer, rectum cancer, and stomach cancer. The generic name of this medication is Capecitabine, and it is a nucleoside inhibitor. This medicine is an antineoplastic agent that triggers apoptosis in the cancerous cells and slows down the progression of cancer. It is used alone or in combination with some other medicines as a part of chemotherapy.
Side Effects
Capegard 500 may interact with blood thinners like warfarin, increasing the risk of serious bleeding, especially in cancer patients over 60. Seek immediate medical help if you notice unusual bleeding, blood in vomit, stools, or urine, or easy bruising. Capecitabine 500mg may also lower white blood cell counts, increasing the risk of infections. Regular blood tests are needed to monitor blood cells, as well as heart, liver, and uric acid levels. Capegard 500mg Tablet may cause some side effects that vary from one patient to another. Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Contact your healthcare provider if you face any unusual or persistent side effects.
Common side effects include:
- Diarrhea
- Nausea
- Vomiting
- Fatigue
- Hair loss
- Constipation
- Dehydration
- Pain
- Fever
- Edema
- Hand-foot syndrome
- Mouth sores
- Dizziness
- Anemia
How To Use
- The dosage of Capegard 500mg Tablet varies according to the type of cancer, the treatment strategy, and the patient’s overall health condition.
- It should be taken exactly as prescribed by the doctor at a fixed time every day to get effective results.
- Take this tablet orally after a meal.
- Don't chew, crush, or break it.
Safety Advice
Avoid the consumption of alcohol while taking Capegard 500mg Tablet. Alcohol can reduce the effectiveness of the medicine and worsen the symptoms.
Capegard 500mg Tablet is not recommended during pregnancy as it is unsafe for the developing fetus. Doctors rarely prescribe this medicine in pregnancy.
Capegard 500mg Tablet should be avoided during breastfeeding as it may cause toxicity to the baby.
Capegard 500mg Tablet may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving or operating heavy machinery.
Consumption of Capegard 500mg Tablet should be avoided without informing the doctor if you have any kidney-related issues.
Consumption of Capegard 500mg Tablet should be avoided without informing the doctor if you have any liver-related issues.
Missed Doses
- It is not advisable to miss any dose of Capegard 500mg and do not double the dose to compensate.
- In case you miss a dose, consult your doctor immediately
FAQs
Capegard 500mg tablet is an anticancer medication that is primarily used in the treatment of breast, colon, rectum, and stomach cancer.
References
- Pallavi, K., Srinivasa Babu, P., & Kishore Babu, G. (2016). Development and validation of UV spectrophotometric method and RP-HPLC method for estimation of capecitabine in bulk and tablet dosage forms. Int J Appl Pharm, 8(3), 24-9. - https://www.researchgate.net/publication/306214579_Development_and_validation_of_UV_spectrophotometric_method_and_RP-HPLC_method_for_estimation_of_capecitabine_in_bulk_and_tablet_dosage_forms
- SAI, K. J., MONDAL, S., CHAKRABORTY, S., & REVU, B. N. (2023). A Sensitive and economical different spectroscopic methods development and validation for the quantification of capecitabine and stress degradation studies. Int J App Pharm, 15(3), 90-99 - https://journals.innovareacademics.in/index.php/ijap/article/view/47316
- Sumanta, M., Narendra, R., & Ganapaty, S. Novel derivative spectrophotometric methods for the quantification of Capecitabine.
- Ghule, M. K. E. (2019). A COMPARATIVE STUDY ON FINANCIAL STATEMENT ANALYSIS OF CIPLA LIMITED (Doctoral dissertation, University Of Mumbai).
- Mondal, S. U. M. A. N. T. A., Narendra, R. E. D. D. Y., Ghosh, D., & Ganapaty, S. E. R. U. (2016). Development and validation of RP-HPLC and UV spectrophotometric methods for the quantification of Capecitabine. In International Conference on Harmonization guidelines Q2 (R1) (Vol. 17, p. 25).
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
